Efficacy, Safety and Pharmacodynamic/Pharmacokinetic Study of Fimasartan (BR-A-657•K)

NCT00937651 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

81

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension

Interventions

DRUG: Placebo
DRUG: Fimasartan (BR-A-657•K) 20 mg
DRUG: Fimasartan (BR-A-657•K) 60 mg
DRUG: Fimasartan (BR-A-657•K) 180 mg

Sponsor

Boryung Pharmaceutical Co., Ltd